bolt_mostly8543 on Bluemong

Robert I. Blum, President & CEO of Cytokinetics (NASDAQ:CYTK), reported the sale of 7,500 shares on Aug. 10, 2026, as disclosed in a recent SEC Form 4 filing.
Metric
Value
Transaction value
$575,700

#NASDAQ #transaction

22 days ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from bolt_mostly8543 , click on at the bottom under it

Sign in

No replys yet!